CVS Caremark to resume coverage of Lilly’s Zepbound weight loss drug
CVS Caremark will reinstate coverage for the weight loss drug Zepbound, effective October 1, following its removal from the formulary ...
Tag: Lillys
Study shows participants lost up to 85 pounds using Lilly’s weight loss drug
Eli Lilly’s new weight loss drug, retatrutide, has shown promising results in a late-stage clinical trial, with participants losing up ...
Eli Lilly’s blockbuster weight-loss drug no longer in shortage in US: USFDA | World News
Eli Lilly's weight-loss drug tirzepatide, sold as Mounjaro and Zepbound, is no longer in shortage in the US, according to ...
Eli Lilly’s weekly insulin intensifies race with Novo Nordisk
A pair of late-stage trials conducted by Eli Lilly found that their experimental once-weekly insulin can effectively lower blood sugar ...
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.